Patent information
IP India · live recordAbstract
The present invention disclosed a process for the preparation of etomidate in which the R-(+)-phenylethylamine is reacted with ethyl chloroacetate in absence of a solvent to give R-(+)-N-[(ethoxycarbonyl)methyl]-l-phenylethylamine, which is formylated to give R-(+)-(N-formyl-N-[(ethoxycarbonyl)methyl]-l-phenylethylamine. This is further C-formylatedto give R-(+)-ethyl-2-[formy(l-phenylethyl)amino]-3-hydroxyacrylate . The obtained compound is cyclized to obtain R-(+)-l-(l-phenylethyl)-2-mercapto-5-(ethoxycarbonyl)imidazoleand this is further desulferisedin presence of hydrogen peroxide, water and a solvent to obtain R-(+)-etomidate.
Applicants
1Inventors
5Specification
Show full textCollapse
Field of Invention
The present invention relates to a process for preparing the ethyl-1-[(1 R)-(+)-l-phenylethyl]-lH-imidazole-5-carboxylate, commonly known as R-(+)-etomidate, having the formula I:
Background of the Invention
R-(+)-etomidate is a carboxylated imidazole derivative that has anesthetic and amnestic properties. It is a short acting intravenous anaesthetic agent used for the induction of general anaesthesia and for sedation for short procedures such as reduction of dislocated joints and cardioversion.
Etomidate was disclosed for the first time in US patent3,354,173.This patent describes a process for the preparation of etomidate by reacting